Drug Delivery: Breaching the Hyaluronan Barrier with PH20‐Fc Facilitates Intratumoral Permeation and Enhances Antitumor Efficiency: A Comparative Investigation of Typical Therapeutic Agents in Different Nanoscales (Adv. Healthcare Mater. 22/2016)
作者
Shan Liu,Wei Wei,Bo Xie,Hua Yue,Dezhi Ni,Yali Bao,Guanghui Ma,Zhiguo G. Su
On page 2872, Guanghui Ma, Zhiguo Su, and co-workers construct a long-acting hyaluronidase (PH20-Fc) as a diffusion facilitator for typical anticancer agents: doxorubicin, trastuzumab, and gold nanorod. Although effective, the performances vary among these therapeutic agents. Trastuzumab benefits most from PH20-Fc with a best improvement in penetration and accumulation. Their systematic investigations thus reveal the importance of therapeutics size effect when using diffusion facilitator for anticancer therapy.